FFCP PHASE1:Mm9::chr13:61105069..61105110,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=31|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:61105069..61105110,+|id=chr13:61105069..61105110,+|ontology_enrichment_celltype=CL:0000349!4.77e-07!3;CL:0000351!4.77e-07!3|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0005631!4.90e-53!3;UBERON:0000478!4.90e-53!3;UBERON:0000158!4.90e-53!3;UBERON:0001987!6.35e-36!2;UBERON:0003124!6.35e-36!2;UBERON:0004340!6.35e-36!2;UBERON:0000305!7.74e-19!1;UBERON:0005795!1.43e-18!4;UBERON:0000995!1.43e-18!4;UBERON:0003975!4.39e-15!5;UBERON:0003134!8.03e-10!8;UBERON:0004175!7.68e-09!9;UBERON:0000474!7.68e-09!9;UBERON:0003100!2.08e-07!11;UBERON:0004923!2.18e-07!24;UBERON:0004871!3.64e-07!3;UBERON:0000358!4.77e-07!3;UBERON:0000307!4.77e-07!3|ontology_enrichment_uberon_v019_2=UBERON:0001987,4.52e-44,2;UBERON:0003124,4.52e-44,2;UBERON:0004340,4.52e-44,2;UBERON:0005631,5.61e-30,3;UBERON:0000478,5.61e-30,3;UBERON:0000158,5.61e-30,3;UBERON:0005795,6.52e-23,4;UBERON:0000995,6.52e-23,4;UBERON:0003975,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.148442139064825,0,0,0,0,0,0,0.741584903203122,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.469343416127421,9.53244318887191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167884616364078,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr13:61105069..61105110,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=31 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:61105069..61105110,+ | |||
|description=CAGE_peak_at_chr13:61105069..61105110,+ | |||
|id=chr13:61105069..61105110,+ | |||
|ontology_enrichment_celltype=CL:0000349!4.77e-07!3;CL:0000351!4.77e-07!3 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0005631!4.90e-53!3;UBERON:0000478!4.90e-53!3;UBERON:0000158!4.90e-53!3;UBERON:0001987!6.35e-36!2;UBERON:0003124!6.35e-36!2;UBERON:0004340!6.35e-36!2;UBERON:0000305!7.74e-19!1;UBERON:0005795!1.43e-18!4;UBERON:0000995!1.43e-18!4;UBERON:0003975!4.39e-15!5;UBERON:0003134!8.03e-10!8;UBERON:0004175!7.68e-09!9;UBERON:0000474!7.68e-09!9;UBERON:0003100!2.08e-07!11;UBERON:0004923!2.18e-07!24;UBERON:0004871!3.64e-07!3;UBERON:0000358!4.77e-07!3;UBERON:0000307!4.77e-07!3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001987,4.52e-44,2;UBERON:0003124,4.52e-44,2;UBERON:0004340,4.52e-44,2;UBERON:0005631,5.61e-30,3;UBERON:0000478,5.61e-30,3;UBERON:0000158,5.61e-30,3;UBERON:0005795,6.52e-23,4;UBERON:0000995,6.52e-23,4;UBERON:0003975,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.148442139064825,0,0,0,0,0,0,0.741584903203122,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.469343416127421,9.53244318887191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167884616364078,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:61105069..61105110,+ | |||
}} |
Latest revision as of 05:52, 6 August 2015
Short description: | p@chr13:61105069..61105110, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:61105069..61105110, + |
Coexpression cluster: | MCL_coexpression_mm9:31 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
placenta | 4.52e-44 | 2 |
chorion | 4.52e-44 | 2 |
allantois | 4.52e-44 | 2 |
extraembryonic membrane | 5.61e-30 | 3 |
extraembryonic structure | 5.61e-30 | 3 |
membranous layer | 5.61e-30 | 3 |
embryonic uterus | 6.52e-23 | 4 |
uterus | 6.52e-23 | 4 |
internal female genitalia | 1.16e-18 | 5 |
female reproductive organ | 2.93e-12 | 8 |
internal genitalia | 4.56e-11 | 9 |
female reproductive system | 4.56e-11 | 9 |
female organism | 2.51e-09 | 11 |